Subscribe To
Acadia pharmaceuticals (acad) reports q4 loss, tops revenue estimates
Acadia (ACAD) delivered earnings and revenue surprises of -4% and 1.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues ...
February 27, 2023, 6:49 pm
Biomarin pharmaceutical (bmrn) q4 earnings lag estimates
BioMarin (BMRN) delivered earnings and revenue surprises of -7.69% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold c...
February 27, 2023, 6:49 pm
Bausch + lomb: brent saunders return bodes well for shareholders
Brent Saunders led Bausch + Lomb Corporation when it was sold to Valeant pharmaceuticals. He later led ...
February 27, 2023, 5:22 pm
Ironwood pharmaceuticals to participate in upcoming investor conferences
BOSTON--(BUSINESS WIRE)--Ironwood pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company...
February 27, 2023, 4:01 pm
Cullinan oncology to participate in cowen’s 43rd annual health care conference
CAMBRIDGE, Mass., Feb. 27, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan Oncology”) a bio...
February 27, 2023, 1:00 pm
Reata stock plummets as official's exit shakes up fda's neuroscience unit
The FDA will decide whether to approve a neurological disease drug from Reata pharmaceuticals this week...
February 27, 2023, 12:47 pm
Omniab: legitimate competition to abcellera in antibody discovery
OmniAb recently completed its separation from Ligand pharmaceuticals and is now a publicly traded indep...
February 27, 2023, 12:16 pm
Is bellicum pharmaceuticals (blcm) outperforming other medical stocks this year?
Here is how Bellicum pharmaceuticals (BLCM) and Castle Biosciences, Inc. (CSTL) have performed compared...
February 27, 2023, 11:17 am
Scholar rock to present at the cowen 43rd annual health care conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical...
February 27, 2023, 8:00 am
Calliditas: underfollowed swedish biotech focusing on rare kidney disease
Calliditas Therapeutics is a commercial-stage biopharmaceutical company based in Sweden focused on deve...
February 27, 2023, 1:41 am
This pharmaceuticals company looks to be a better pick over procter & gamble stock
There is more to the comparison, and in the sections below, we discuss the possible returns for P&G and AbbVie in the next three years....
February 27, 2023, 1:26 am
Hikma pharmaceuticals plc (hkmpf) q4 2022 earnings call transcript
Hikma pharmaceuticals PLC (OTCPK:HKMPF) Q4 2022 Earnings Conference Call February 23, 2023 6:00 AM ET C...
February 26, 2023, 1:13 pm
Why apellis pharmaceuticals stock surged this week
A highly eventful five days for the company saw bulls pile into its shares....
February 24, 2023, 6:08 pm
Agios pharmaceuticals (agio) moves to strong buy: rationale behind the upgrade
Agios pharmaceuticals (AGIO) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing opti...
February 24, 2023, 1:33 pm
Opko health (opk) q4 earnings match estimates, revenues top
Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in pharmaceuticals segment, its overall ...
February 24, 2023, 12:03 pm
Why is timber pharmaceuticals (tmbr) stock up 61% today?
Timber pharmaceuticals (NYSEMKT: TMBR ) stock is taking off on Friday after getting an orphan drug desi...
February 24, 2023, 11:57 am
Why obseva (obsv) stock is down 36% today
ObsEva (NASDAQ: OBSV ) is trending on social media, and OBSV stock is tumbling 36% to 10.85 cents. The Swiss bio...
February 24, 2023, 10:54 am
Alnylam (alny) q4 earnings top, product sales boost revenues
Alnylam pharmaceuticals (ALNY) reports better-than-expected fourth-quarter 2022 results. Total revenues...
February 24, 2023, 10:32 am
Sellas life sciences raises $20 million from public offering of stock, warrants
Sellas Life Sciences Group Inc. SLS, -3.40% said Friday that it raised $20.0 million, through the public sale of common shares and warrants to buy sto...
February 24, 2023, 8:42 am
Why is sellas life sciences (sls) stock down 38% today?
SELLAS Life Sciences (NASDAQ: SLS ) stock is falling on Friday after the late-stage clinical biopharmaceutical...
February 24, 2023, 8:29 am